Masanori Baba

Q: What Schools Are Affiliated With Masanori Baba

Masanori Baba is affiliated with the following schools: Kagoshima University, KU Leuven, Fukushima Medical University, Osaka University

Masanori Baba's AcademicInfluence.com Rankings

Masanori Baba

Chemistry

#3381

World Rank

#4396

Historical Rank

Organic Chemistry

#531

World Rank

#614

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Masanori Baba's Degrees

PhD Chemistry University of Tokyo
Masters Chemistry University of Tokyo
Bachelors Chemistry University of Tokyo

Why Is Masanori Baba Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Masanori Baba's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. (1988) (1518)
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. (1999) (761)
Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus (1988) (506)
Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. (1987) (469)
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. (1988) (439)
A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. (1989) (356)
Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. (2003) (350)
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. (1987) (323)
Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. (1987) (305)
Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. (2003) (280)
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents. (1987) (275)
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. (1989) (269)
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents (1988) (245)
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. (1992) (232)
Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine (2011) (212)
Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. (1987) (205)
Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). (1988) (196)
Targeting of Antigen to Dendritic Cells with Poly(γ-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity1 (2007) (189)
Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. (1989) (187)
Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. (1988) (179)
The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species. (1988) (174)
Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues. (1988) (173)
Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. (1987) (168)
Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. (2007) (163)
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro (1987) (156)
An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. (1991) (152)
Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. (2003) (150)
Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety. (2000) (146)
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. (1992) (146)
Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. (1983) (143)
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. (1991) (141)
Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: effect of substitutions at the C-6 phenyl ring and at the C-5 position on anti-HIV-1 activity. (1992) (131)
A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). (1991) (126)
The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway. (2011) (118)
Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis. (1987) (117)
T134, a Small-Molecule CXCR4 Inhibitor, Has No Cross-Drug Resistance with AMD3100, a CXCR4 Antagonist with a Different Structure (1999) (115)
Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. (1988) (114)
Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation (1990) (109)
Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses (1992) (108)
Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. (1989) (107)
N-alkylated nitrogen-in-the-ring sugars: conformational basis of inhibition of glycosidases and HIV-1 replication. (1995) (107)
Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants. (1999) (105)
Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: Potential applications (2007) (105)
TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans (2005) (104)
Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro (1994) (104)
A Role of RNA Helicase A in cis-Acting Transactivation Response Element-mediated Transcriptional Regulation of Human Immunodeficiency Virus Type 1* (2001) (102)
Sulfated Polysaccharides as Potent Inhibitors of HIV‐Induced Syncytium Formation: A New Strategy Towards AIDS Chemotherapy (1990) (99)
Isolation and Characterization of Human Immunodeficiency Virus Type 1 Resistant to the Small-Molecule CCR5 Antagonist TAK-652 (2006) (93)
Poly(γ‐glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: Potential for an AIDS vaccine (2008) (90)
Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. (1991) (89)
Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells. (1989) (89)
Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety. (2006) (84)
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. (1992) (84)
Anti-Hiv-1 Activity of 2′,3′-Dideoxinucleoside Analogues : Structure-Activity Relationship (1989) (82)
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety. (2005) (81)
Sulphated Polymers are Potent and Selective Inhibitors of Various Enveloped Viruses, Including Herpes Simplex Virus, Cytomegalovirus, Vesicular Stomatitis Virus, Respiratory Syncytial Virus, and Toga-, Arena- and Retroviruses (1990) (78)
Anti-HIV activity of dextran sulphate as determined under different experimental conditions. (1989) (77)
Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. (1998) (73)
Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives (1997) (72)
Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). (1991) (69)
Synthesis of a highly active new anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine. (2003) (68)
Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity. (1990) (68)
Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives. (1991) (67)
Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. (1991) (66)
Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro (1987) (65)
Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives. (1998) (65)
Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein. (2004) (63)
Mucosal immunization with inactivated HIV‐1‐capturing nanospheres induces a significant HIV‐1‐specific vaginal antibody response in mice (2003) (63)
Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity. (2006) (62)
The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro. (1987) (62)
Recent status of HIV-1 gene expression inhibitors. (2006) (61)
Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors. (1992) (61)
Novel 4′-Substituted Stavudine Analog with Improved Anti-Human Immunodeficiency Virus Activity and Decreased Cytotoxicity (2004) (60)
A Cryopreservation Method of Human Peripheral Blood Mononuclear Cells for Efficient Production of Dendritic Cells (1997) (60)
Modulation of innate and adaptive immunity by biodegradable nanoparticles. (2009) (60)
Capture of HIV-1 gp120 and Virions by Lectin-Immobilized Polystyrene Nanospheres† (1998) (58)
Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells. (1998) (58)
Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus. (1988) (58)
Induction of HIV‐specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV‐capturing nanospheres in macaques (2004) (57)
Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. (2000) (57)
Human Follicular Dendritic Cells Remain Uninfected and Capture Human Immunodeficiency Virus Type 1 through CD54-CD11a Interaction (1999) (57)
Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. (1991) (55)
Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro. (1987) (55)
Induction of Potent CD8+ T-Cell Responses by Novel Biodegradable Nanoparticles Carrying Human Immunodeficiency Virus Type 1 gp120 (2007) (54)
Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo. (2013) (52)
Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate (1996) (51)
Amphiphilic Poly(Amino Acid) Nanoparticles Induce Size‐Dependent Dendritic Cell Maturation (2010) (51)
Effects of protease inhibitors on replication of various myxoviruses (1992) (50)
Gamma-carboline derivatives with anti-bovine viral diarrhea virus (BVDV) activity. (2008) (49)
Highly Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by TAK-220, an Orally Bioavailable Small-Molecule CCR5 Antagonist (2005) (49)
Broad-Spectrum Antiviral Activity and Mechanism of Antiviral Action of the Fluoroquinolone Derivative K-12 (1998) (48)
Potential anti-AIDS agents. Synthesis and antiviral activity of naphthalenesulfonic acid derivatives against HIV-1 and HIV-2. (1991) (46)
Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro. (1989) (46)
Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. (1988) (45)
Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: a potential agent against HIV-1 encephalopathy. (2001) (44)
Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice. (2011) (43)
Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry. (1989) (43)
α‐Lipoic acid blocks HIV‐1 LTR‐dependent expression of hygromycin resistance in THP‐1 stable transformants (1996) (43)
CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives. (2005) (43)
TRAIL-Transduced Dendritic Cells Protect Mice from Acute Graft-versus-Host Disease and Leukemia Relapse1 (2005) (42)
Anti-Human Immunodeficiency Virus Type 1 Activity and Resistance Profile of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine In Vitro (2005) (42)
Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442. (1993) (42)
Orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activity of 1-benzothiepine 1,1-dioxide and 1-benzazepine derivatives containing a tertiary amine moiety. (2004) (42)
Fluorinated functional materials possessing biological activities: gel formation of novel fluoroalkylated end-capped 2-acrylamido-2-methylpropanesulfonic acid polymers under non-crosslinked conditions (1998) (41)
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside. (1988) (40)
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. (2010) (40)
In vitro Antimyxovirus and Anti-Human Immunodeficiency Virus Activities of Polyoxometalates (1995) (40)
Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37. (2000) (40)
Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription. (2014) (40)
Concanavalin A‐immobilized polystyrene nanospheres capture HIV‐1 virions and gp120: Potential approach towards prevention of viral transmission (1998) (39)
Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-alpha-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. (1999) (39)
Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1. (2000) (38)
SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A NIGELLA SATIVA SEED FORMULATION (2016) (38)
Highly potent and selective inhibition of HIV-1 replication by 6-phenylthiouracil derivatives. (1992) (38)
Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains (1995) (35)
Highly Enhanced Expression of CD70 on Human T-Lymphotropic Virus Type 1-Carrying T-Cell Lines and Adult T-Cell Leukemia Cells (2008) (35)
Inhibition of bovine viral diarrhea virus (BVDV) by mizoribine: synergistic effect of combination with interferon-alpha. (2004) (35)
Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT. (2007) (35)
Hept Derivatives: 6-Benzyl-1-ethoxymethyl-5-isopropyluracil (MKC-442) (1995) (34)
Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds. (1989) (34)
9-Hydroxymethylcyclopropylidenemethylenyladenine: The design, facile synthesis, isomer separation and anti-HIV-1 activities (1998) (34)
Inhibitors of HIV-1 gene expression and transcription. (2004) (34)
Diterpenoids from Euphorbia paralias. (2001) (34)
Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effect. (1993) (33)
Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro (1984) (32)
Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells. (1999) (32)
Synthesis and surfactant properties of novel acrylic acid co-oligomers containing fluoroalkylated end-groups: a new approach to polymeric inhibitors of human immunodeficiency virus type-1 (1996) (32)
5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine. (1989) (30)
Synthesis and anti-HIV activity of 4'-substituted 4'-thiothymidines: a new entry based on nucleophilic substitution of the 4'-acetoxy group. (2008) (30)
Effect of human serum on the in vitro anti-HIV-1 activity of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives as related to their lipophilicity and serum protein binding. (1993) (30)
Potential anti-AIDS naphthalenesulfonic acid derivatives. Synthesis and inhibition of HIV-1 induced cytopathogenesis and HIV-1 and HIV-2 reverse transcriptase activities. (1992) (30)
Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives. (1992) (29)
Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles. (2009) (29)
Orally active CCR5 antagonists as anti-HIV-1 agents 2: synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moiety. (2004) (29)
Induction of mucosal IgA following intravaginal administration of inactivated HIV‐1‐capturing nanospheres in mice (2002) (29)
CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives. (2004) (29)
Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1 (2013) (29)
Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives (1990) (27)
Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, and reverse transcriptase activity. (1991) (27)
Association of CD40 Ligand Expression on HTLV‐I‐Infected T Cells and Maturation of Dendritic Cells (2001) (26)
Structural development studies of anti-hepatitis C virus agents with a phenanthridinone skeleton. (2010) (26)
Modulation of Gene Expression Related to Toll-Like Receptor Signaling in Dendritic Cells by Poly(γ-Glutamic Acid) Nanoparticles (2010) (25)
Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery. (2012) (25)
Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo. (2013) (25)
Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase. (1992) (25)
Synthesis and anti-human immunodeficiency virus activity of 4'-branched (+/-)-4'-thiostavudines. (2006) (25)
Utilization of wieland furoxan synthesis for preparation of 4-aryl-1,2,5-oxadiazole-3-yl carbamate derivatives having potent anti-HIV activity (1996) (24)
Gelation of fluoroalkylated 2-acrylamido-2-methylpropanesulfonic acid oligomers as potential for prevention of HIV-1 transmission (1998) (23)
Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors (2017) (23)
Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro (1991) (23)
Cellular factors as alternative targets for inhibition of HIV-1. (1997) (23)
Isolation and Characterization of Human Immunodeficiency Virus Type-1 Mutants Resistant to the Non-Nucleotide Reverse Transcriptase Inhibitor MKC-442 (1995) (23)
Induction of dendritic cell‐mediated immune responses against HIV‐1 by antigen‐capturing nanospheres in mice (2005) (22)
Ingenol Derivatives are Highly Potent and Selective Inhibitors of HIV Replication in Vitro (1996) (22)
Structure based medicinal chemistry approach to develop 4-methyl-7-deazaadenine carbocyclic nucleosides as anti-HCV agent. (2012) (22)
AIDS vaccine: Intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres. (2005) (22)
Antiviral Activities of Mizoribine and other Inosine Monophosphate Dehydrogenase Inhibitors against Several Ortho- and Paramyxoviruses (1994) (22)
Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus. (2010) (22)
Upregulation of HIV-1 replication in chronically infected cells by ingenol derivatives (1998) (22)
Inhibitory Effects of Small-Molecule CCR5 Antagonists on Human Immunodeficiency Virus Type 1 Envelope-Mediated Membrane Fusion and Viral Replication (2001) (22)
Colorimetric Lactate Dehydrogenase (LDH) Assay for Evaluation of Antiviral Activity against Bovine Viral Diarrhoea Virus (BVDV) in Vitro (2005) (21)
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Acutely and Chronically Infected Cells by EM2487, a Novel Substance Produced by a Streptomyces Species (1999) (21)
Phosphonylmethoxyalkyl derivatives of purines and pyrimides: A new class of antiviral agents active against both herpesviruses and retroviruses☆ (1987) (21)
The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro (2020) (21)
Four New Chlorinated Azaphilones, Helicusins A-D, Closely Related to 7-epi-Sclerotiorin, from an Ascomycetous Fungus, Talaromyces helicus. (1995) (21)
Antibacterial activity of fluoroalkylated allyl-and diallyl-ammonium chloride oligomers (1997) (21)
Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro. (1990) (20)
Synthesis and properties of fluoroalkylated end-capped betaine polymers (1999) (20)
Synthesis and surfactant properties of fluoroalkylated sulfonic acid oligomers as a new class of human immunodeficiency virus inhibitors (1996) (20)
Stereoselective Synthesis of 4'-α-Alkylcarbovir Derivatives Based on an Asymmetric Synthesis or Chemoenzymatic Procedure (1999) (19)
Novel Reporter T-Cell Line Highly Susceptible to Both CCR5- and CXCR4-Using Human Immunodeficiency Virus Type 1 and Its Application to Drug Susceptibility Tests (2003) (19)
Inhibition of Human Immunodeficiency Virus Type 1 Replication by Combination of Transcription Inhibitor K-12 and Other Antiretroviral Agents in Acutely and Chronically Infected Cells (1999) (19)
HIV-1-infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases. (2005) (19)
Fused heterocyclic amido compounds as anti-hepatitis C virus agents. (2011) (19)
Pointer the Role of Breast Cancer Resistance Protein (BCRP/ABCG2) in Cellular Resistance to HIV-1 Nucleoside Reverse Transcriptase Inhibitors (2005) (19)
Comparison of the Phosphorylation of 4′-Ethynyl 2′,3′-Dihydro-3′-Deoxythymidine with That of Other Anti-Human Immunodeficiency Virus Thymidine Analogs (2007) (19)
In vitro activity of mannan sulfate, a novel sulfated polysaccharide, against human immunodeficiency virus type 1 and other enveloped viruses (1989) (19)
Anti-HIV-1 activity of thiadiazole derivatives: structure-activity relationship, reverse transcriptase inhibition, and lipophilicity. (1996) (19)
Establishment of a bioassay to determine serum levels of dextran sulfate and pentosan polysulfate, two potent inhibitors of human immunodeficiency virus. (1990) (18)
Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide Analogues. (2014) (18)
Selective inhibition of HIV-1 replication by the CDK9 inhibitor FIT-039. (2015) (18)
Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells. (1999) (18)
Highly potent and selective inhibition of bovine viral diarrhea virus replication by γ-carboline derivatives. (2010) (18)
Mechanism of Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase by a Stavudine Analogue, 4′-Ethynyl Stavudine Triphosphate (2008) (18)
Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Thymidine Analog (2007) (18)
Synthesis of some analogues of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)thymine (hept) which have different types of acyclic structures (1992) (18)
Sulfonic acid polymers are potent inhibitors of HIV-1 induced cytopathogenicity and the reverse transcriptases of both HIV-1 and HIV-2. (1993) (17)
Development of Core-Corona Type Polymeric Nanoparticles as an Anti-HIV-1 Vaccine (2007) (17)
Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Design and synthesis of thiazolidenebenzenesulfonamides. (2004) (17)
Potent and Selective Inhibition of Tat-Dependent HIV-1 Replication in Chronically Infected Cells by a Novel Naphthalene Derivative JTK-101 (2007) (17)
Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives. (2005) (17)
Inhibitory effects of selected antiviral compounds on newly isolated clinical varicella-zoster virus strains. (1986) (16)
HTLV‐I‐infected T cells activate autologous CD4+ T cells susceptible to HTLV‐I infection in a co‐stimulatory molecule‐dependent fashion (1997) (16)
Anti-HIV-1 Activity and Structure-Activity Relationship of Cepharanoline Derivatives in Chronically Infected Cells (2001) (16)
Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1 (2005) (16)
Highly potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by the HIV-1-specific reverse transcriptase inhibitors (1992) (16)
Novel amodiaquine derivatives potently inhibit Ebola virus infection (2018) (16)
Identification of Novel Inhibitors of Human Immunodeficiency Virus Type 1 Replication by In Silico Screening Targeting Cyclin T1/Tat Interaction (2012) (16)
Inhibition of porcine endogenous retrovirus (PERV) replication by HIV-1 gene expression inhibitors. (2009) (16)
Synthesis of naphthalenesulfonic acid small molecules as selective inhibitors of the DNA polymerase and ribonuclease H activities of HIV-1 reverse transcriptase. (1994) (16)
Lithiation of Uracilnucleosides and its Application to the Synthesis of a New Class of Anti-HIV-1 Acyclonucleosides (1991) (16)
Prevention of murine AIDS development by (R)-9-(2-phosphonylmethoxypropyl)adenine. (1998) (15)
Pointer 4'-Ethynylstavudine (4'-Ed4T) Has Potent Anti-HIV-1 Activity with Reduced Toxicity and Shows a Unique Activity Profile against Drug-Resistant Mutants (2005) (15)
Synthesis of 1-benzyl-3-(3,5-dimethylbenzyl)Uracil Derivatives with Potential Anti-HIV Activity (2011) (15)
Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative k-37. (2002) (15)
Balancing Antiviral Potency and Host Toxicity: Identifying a Nucleotide Inhibitor with an Optimal Kinetic Phenotype for HIV-1 Reverse Transcriptase (2012) (15)
Inhibitory Effect of Pyridobenzoazoles on Orthomyxo-and Paramyxovirus Replication in vitro (1992) (15)
Nucleosides and nucleotides. 128. (2′S)-2′-deoxy-2′-C-methyl-5-iodouridine (SMIU) as a novel potent anti-herpes virus agent☆ (1994) (15)
Inhibitory effect of cepharanthine on dendritic cell activation and function. (2011) (15)
Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro. (1989) (15)
CCR5 antagonists as anti-HIV-1 agents. Part 2: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N'-diphenylureas. (2004) (14)
Follicular dendritic cells in vitro are not susceptible to infection by HIV‐1 (1996) (14)
First total synthesis of Mer-N5075A and a diastereomeric mixture of α and β-MAPI, new HIV-I protease inhibitors from a species of Streptomyces (2001) (14)
Synthesis of (±)-4′-Ethynyl and 4′-Cyano Carbocyclic Analogues of Stavudine (d4T) (2005) (14)
Three‐drug combination of MKC‐442, lamivudine and zidovudine in vitro: potential approach towards effective chemotherapy against HIV‐1 (1997) (14)
Discovery of diphenylmethane analogs as anti-bovine diarrhea viral agents. (2009) (14)
Synthesis of novel fluoroalkylated 4-vinylpyridinium chloride oligomers as functional materials possessing surfactant and biological properties (1997) (14)
Impact of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations P119S and T165A on 4′-Ethynylthymidine Analog Resistance Profile (2009) (14)
Selective Inhibition of Porcine Endogenous Retrovirus Replication in Human Cells by Acyclic Nucleoside Phosphonates (2007) (14)
Synthesis and surfactant properties of novel acrylic acid oligomers containing perfluoro-oxa-alkylene units: an approach to anti-human immunodeficiency virus type-1 agents (1995) (14)
Synthesis and Properties of Gelling Fluoroalkylated End-Capped Oligomers Containing Hydroxy Segments (1998) (13)
Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination. (2019) (13)
2-Glycineamide-5-chlorophenyl 2-pyrryl ketone, a non-benzodiazepin Tat antagonist, is effective against acute and chronic HIV-1 infections in vitro. (1996) (13)
Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay (2015) (13)
[Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine]. (2007) (13)
Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives. (1993) (13)
Synthesis and Anti‐HIV Activity of 4′‐Cyano‐2′,3′‐didehydro‐3′‐deoxythymidine (2004) (13)
Sho‐Saiko‐To, a Traditional Kampo Medicine, Enhances the Anti‐HIV‐1 Activity of Lamivudine (3TC) In Vitro (1997) (13)
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon. (1991) (13)
Naphthalenesulphonic Acid Derivatives as Potential anti-HIV-1 Agents. Chemistry, Biology and Molecular Modelling of Their Inhibition of Reverse Transcriptase (1991) (13)
Synthesis of 4'-Ethynyl-2'-deoxy-4'-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI. (2011) (13)
EM2487, a novel anti-HIV-1 antibiotic, produced by Streptomyces sp. Mer-2487: taxonomy, fermentation, biological properties, isolation and structure elucidation. (1999) (13)
Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro. (1996) (12)
Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents. (2013) (12)
Design and Synthesis of Regioisomeric Analogues of a Specific Anti-HIV-1 Agent 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) (1994) (12)
Synthesis of benzodithiol-2-yl-substituted nucleoside derivatives as lead compounds having anti-bovine viral diarrhea virus activity. (2004) (12)
Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells. (2013) (12)
Galectin-3 is involved in HIV-1 expression through NF-κB activation and associated with Tat in latently infected cells. (2019) (12)
Stavudine selectively induces apoptosis in HIV type 1-infected cells. (1997) (12)
Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives. (2011) (12)
Anti-Bovine Viral Diarrhoea Virus and Hepatitis C Virus Activity of the Cyclooxygenase Inhibitor SC-560 (2009) (12)
Synthesis and surfactant properties of fluoroalkylated acrylic acid co-oligomers containing dimethylsilicone segments as potential inhibitors of HIV-1 (1997) (12)
Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells. (1996) (12)
Synthesis of novel fluoroalkylated oligomers containing phosphinico segments : A new approach to functional materials possessing anti-HIV 1 activity (1997) (11)
HIV-1-infected myelomonocytic cells are resistant to Fas-mediated apoptosis: effect of tumor necrosis factor-α on their Fas expression and apoptosis (1997) (11)
From the chemistry of epoxy-sugar nucleosides to the discovery of anti-HIV agent 4'-ethynylstavudine-Festinavir. (2013) (11)
The role of breast cancer resistance protein (BCRP/ABCG2) in cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. (2005) (11)
Thiadiazole Derivatives: Highly Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 (HIV‐1) Replications In Vitro (1997) (11)
Discovery of tetrahydrotetramethylnaphthalene analogs as adult T-cell leukemia cell-selective proliferation inhibitors in a small chemical library constructed based on multi-template hypothesis. (2009) (11)
A Conformational Mimetic Approach for the Synthesis of Carbocyclic Nucleosides as Anti‐HCV Leads (2013) (11)
Synthesis and Anti‐HIV Activity of 2‐, 3‐, and 4‐Substituted Analogues of 1‐((2‐Hydroxyethoxy)methyl)‐6‐(phenylthio)thymine (HEPT). (1991) (11)
Incomplete Growth of Varicella‐Zoster Virus in Human Monocytes (1983) (10)
Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation. (1991) (10)
Alpba-Oligodeoxynucleotides as Inhibitors of HIV Reverse Transcriptase (1989) (10)
Synthesis of (±)-9-[c-4, t-5-bis(hydroxymethyl)cyclopent-2-en-r-1-yl]-9H-adenine (BCA) derivatives branched at the 4′-position based on intramolecular SH2′ cyclization (2008) (10)
Anti-AIDS drug development : challenges, strategies, and prospects (1995) (10)
Anti-Tat MTT assay: a novel anti-HIV drug screening system using the viral regulatory network of replication. (1995) (10)
Demonstration of d-Octaarginine-Linked Polymers as Promising Adjuvants for Mucosal Vaccination through Influenza Virus Challenge. (2016) (10)
Asymmetric synthesis of novel thioiso dideoxynucleosides with exocyclic methylene as potential antiviral agents. (2004) (10)
Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly. (2019) (10)
Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives (2015) (10)
Structure-activity relationship studies with symmetric naphthalenesulfonic acid derivatives. Synthesis and influence of spacer and naphthalenesulfonic acid moiety on anti-HIV-1 activity. (1993) (10)
Influence of various experimental conditions on the inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on varicella-zoster virus replication in cell culture. (1984) (10)
High-sensitivity analysis of naturally occurring sugar chains, using a novel fluorescent linker molecule. (2009) (9)
Synthesis and Properties of Fluoroalkylated 2-Acryloxyethyltrimethylammonium Chloride Oligomers (1996) (9)
Synthesis of (±)-4′-ethynyl-5′,5′-difluoro-2′,3′-dehydro-3′-deoxy- carbocyclic thymidine: a difluoromethylidene analogue of promising anti-HIV agent Ed4T (2009) (9)
Inhibition of Human Immunodeficiency Virus Replication by RD6-Y664, a Novel Benzylhydroxylamine Derivative (1999) (9)
Polymethylated γ-Carbolines with Potent anti-Bovine Viral Diarrhea Virus (BVDV) Activity. (2009) (9)
HIV-1-specific reverse transcriptase inhibitors (1995) (9)
Antiviral Activity of a Sulphated Polysaccharide Extracted from the Marine Pseudomonas and Marine Plant Dinoflagellata against Human Immunodeficiency Viruses and other Enveloped Viruses (1996) (9)
Synergistic inhibition of HTLV-1-infected cell proliferation by combination of cepharanthine and a tetramethylnaphthalene derivative. (2012) (9)
Differentiation between human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates by nonradioisotopic reverse transcriptase-typing assay (1994) (9)
Effective induction of cell death on adult T-cell leukaemia cells by HLA-DRbeta-specific small antibody fragment isolated from human antibody phage library. (2009) (9)
Serum and urine concentrations of oral bromovinyldeoxyuridine in humans as monitored by a bioassay system based on varicella‐zoster virus focus inhibition (1987) (9)
Detection of hepatitis C virus genome in human serum by multi‐targeted polymerase chain reaction (1993) (9)
Recent advances of CCR5 antagonists (2006) (8)
Binding site(s) on P-glycoprotein for a newly synthesized photoaffinity analog of agosterol A. (2003) (8)
Retention of Metabolites of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Anti-Human Immunodeficiency Virus Type 1 Thymidine Analog, in Cells (2009) (8)
A New Class of HIV‐1‐Specific 6‐Substituted Acyclouridine Derivatives: Synthesis and Anti‐HIV Activity of 5‐ or 6‐Substituted Analogues of 1‐( (2‐Hydroxyethoxy)methyl)‐6‐(phenylthio)thymine (HEPT). (1991) (8)
In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-adenine against newly isolated clinical varicella-zoster viras strains (1987) (8)
Preparation of fluoroalkyl end-capped cooligomers/silica nanoparticles: A new approach to fluorinated nanoparticle inhibitors of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus (SIVmac) (2007) (8)
An expression of anaplastic large cell lymphoma-associated antigens on HTLV-I-infected CD4+ T cells (1998) (8)
Potent and Selective Activity of Dextrin Sulphate against Human Immunodeficiency Virus Type 1 in vitro (1991) (8)
Synthesis of novel 4′-C-methyl-1′,3′-dioxolane pyrimidine nucleosides and evaluation of its anti-HIV-1 activity (2013) (8)
Synthesis and anti-human immunodeficiency virus type 1 (HIV-1) activity of 3-substituted derivatives of 3'-azido-3'-deoxythymidine (AZT), and inhibition of HIV-1 reverse transcriptase by their 5'-triphosphates. (1992) (8)
Inhibition of HIV-1-Induced Cytopathogenicity, Syncytium Formation, and Virus-Cell Binding by Naphthalenedisulphonic Acids through Interaction with the Viral Envelope gp120 Glycoprotein (1993) (8)
Anti-Human Immunodeficiency Virus Type 1 Activity of Novel 6-Substituted 1-Benzyl-3-(3,5-Dimethylbenzyl)Uracil Derivatives (2012) (7)
Coumermycin A1 is a potent inhibitor of human immunodeficiency virus (HIV) replication in vitro (1989) (7)
Synthesis and properties of novel fluoroalkyl end-capped oligomers containing phosphorus segments (2001) (7)
Effects of the Chemical Structures of Oligoarginines Conjugated to Biocompatible Polymers as a Mucosal Adjuvant on Antibody Induction in Nasal Cavities. (2018) (7)
3'-fluoro-azido-substituted and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside derivatives are potent anti-retrovirus agents (1988) (7)
Anti-Bovine Viral Diarrhoea Virus Activity of Novel Diphenylmethane Derivatives (2010) (7)
Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses. (2019) (7)
Characterization of Human Immunodeficiency Virus Type 1 Strains Resistant to the Non-Nucleoside Reverse Transcriptase Inhibitor RD4–2217 (1999) (7)
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives (2015) (7)
RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses. (1998) (7)
Cepharanthine induces apoptosis through the mitochondria/caspase pathway in murine dendritic cells (2016) (7)
Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st Edition) (2006) (7)
Three-Drug Combinations of Emivirine and Nucleoside Reverse Transcriptase Inhibitors in Vitro: Long-Term Culture of HIV-1-Infected Cells and Breakthrough Viruses (2001) (6)
Regioselective Synthesis of Pyrazolo[3,4-D]Pyrimidine Based Carbocyclic Nucleosides as Possible Antiviral Agent (2016) (6)
Induction of Potent Adaptive Immunity by the Novel Polyion Complex Nanoparticles (2015) (6)
Tuning efficiency of the 4-exo-trig cyclization by the electronic effect: ring closure of 3,3-difluoro-4-pentenyl carbon radicals and synthesis of a gem-difluorocyclobutane nucleoside. (2012) (6)
Induction of thymidine phosphorylase expression by AZT contributes to enhancement of 5'-DFUR cytotoxicity. (2006) (6)
Antiviral Activity of Heparin and Dextran Sulfate against Human Immunodeficiency Virus (HIV) in Vitro (1989) (6)
Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies (2015) (6)
Synthesis and Anti-Hepatitis C Virus Activity of Morpholino Triazine Derivatives (2010) (6)
Organosilicon compounds as adult T-cell leukemia cell proliferation inhibitors. (2013) (6)
Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines. (2004) (6)
Molecular simulation of 5,6-substituted 1-[(2-hydroxyethoxy)methyl]uracils with anti-HIV-1 activity (1996) (6)
Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus / CD 4 cell receptor ( acquired immunodeficiency syndrome / flow cytometry (6)
Allosteric Inhibitors against HIV-1 Reverse Transcriptase: Design and Synthesis of MKC-442 Analogues Having an Ω-Functionalized Acyclic Structure (1998) (6)
Inhibitory effect of 4‐(2,6‐dichlorophenyl)‐1,2,5‐thiadiazol‐3‐yl‐N‐methyl, N‐ethylcarbamate on replication of human immunodeficiency virus type 1 and the mechanism of action (1996) (5)
Selective inhibition of human immunodeficiency virus type 1 replication by novel fluoroalkylated oligomers in vitro. (1994) (5)
HEPT: From an Investigation of Lithiation of Nucleosides Towards a Rational Design of Non-Nucleoside Reverse Transcriptase Inhibitors of HIV-1 (2000) (5)
Synthesis, Anti-HBV, and Anti-HIV Activities of 3'-Halogenated Bis(hydroxymethyl)-cyclopentenyladenines. (2018) (5)
Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of D-octaarginine-linked polymers. (2015) (5)
Selective inhibition of HTLV-1-infected cell proliferation by a novel tetramethylnaphthalene derivative. (2011) (5)
Inhibition of Human T-Lymphotropic Virus Type I Gene Expression by the Streptomyces-Derived Substance EM2487 (2002) (5)
Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation. (2012) (5)
Ingenol derivatives, ingredient of ‘Kansui’, are highly potent inhibitor of HIV (1995) (4)
Anti‐angiogenesis agent DS‐4152 is a potent and selective inhibitor of HIV‐1 replication in vitro (1994) (4)
Synthesis of a Highly Active New anti‐HIV Agent 2′,3′‐Didehydro‐3′‐deoxy‐4′‐ethynylthymidine. (2004) (4)
THE ROLE OF HTLV-I-INFECTED DENDRITIC CELLS IN THE DEVELOPMENT OF HAM/TSP (1999) (4)
The synthesis of novel 6-substituted acyclouridine derivatives which show specific inhibition of HIV-1 (1990) (4)
CCR5 Antagonists as anti-HIV-1 Agents. Part 1. Synthesis and Biological Evaluation of 5-Oxopyrrolidine-3-carboxamide Derivatives. (2004) (4)
Cellular Resistance to HIV-1 Nucleoside Reverse Transcriptase Inhibitors (2002) (4)
Synthesis and Surface Properties of Fluoroalkylated Allyl-and Diallyl-ammonium Chloride Oligomers (1997) (4)
Design and Synthesis of Regioisomeric Analogues of a Specific Anti‐HIV‐ 1 Agent 1‐((2‐Hydroxyethoxy)methyl)‐6‐(phenylthio)thymine (HEPT). (1995) (4)
Synthesis and anti-HIV-1 activity of novel 10-thiaisoalloxazines, a structural analog of C-5 and/or C-6 substituted pyrimidine acyclonucleoside. (2003) (4)
Anti-herpes Activities of Isonucleoside Analogues with Variable Bases at the 2′ Position (1995) (4)
Synthesis and anti-HCV determinant motif identification in pyranone carboxamide scaffold. (2015) (4)
Nitrogen-Containing Fused-Heteroaromatic Compounds as Anti-Bovine Viral Diarrhea Virus (BVDV) Agents (2010) (4)
Establishment of an in vitro assay system mimicking human immunodeficiency virus type 1-induced neural cell death and evaluation of inhibitors thereof. (2003) (4)
39Study of the Retention of Metabolites of 4′-ED4T, A Novel Anti-HIV-1 Thymidine Analog, in Cells (2009) (4)
Synthesis and Antiviral Evaluation of 4'-alkoxy Analogues of 9-(β-D-xylofuranosyl)adenine (2009) (3)
Synthesis and anti-HBV activity of α-stereoisomer of aristeromycin based analogs. (2016) (3)
Syntheses and Properties of Fluoroalkylated Oligomers Containing Oligo(oxyethylene) Units (1998) (3)
Synthesis of a potential photoaffinity labelling reagent for HIV-1 reverse transcriptase (1993) (3)
Inhibition of interleukin‐6‐induced human immunodeficiency virus type 1 expression by anti‐GP130 monoclonal antibody (1997) (3)
Thiadiazole derivatives as highly potent inhibitor of human immunodeficiency virus type 1 (HIV-1) (1995) (3)
Synthesis and properties of fluoroalkyl end-capped sulfobetaine polymers (2004) (3)
3-(5-Dimethylamino-1-Naphthalenesulphonyl)-2-(3-Pyridyl)Thiazolidine (YHI-1) Selectively Inhibits Human Immunodeficiency virus Type 1 (1998) (3)
Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative (2015) (3)
Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres. (1997) (3)
Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients (2016) (3)
Fusion of mature dendritic cells and human T-lymphotropic virus type I infected T cells: its efficiency as an antigen-presenting cell. (2002) (2)
[Advances in antiviral chemotherapy]. (2005) (2)
Synergistic Inhibitory Effect of Acyclovir and Human Native Beta‐Interferon on the Growth of Herpes Simplex Virus Type 2 in Human Embryo Fibroblast Cell Cultures (1986) (2)
Frontiers in Clinical Drug Research- HIV (2015) (2)
Synthesis and Anti-HCV Activity of 4-Methoxy-7H-Pyrrolo[2,3-d] Pyrimidine Carbocyclic Nucleosides (2016) (2)
Synthesis of novel fluoroalkyl end-capped N-vinyl-2-pyrrolidone-acrylic acid co-oligomers by use of fluoroalkanoyl peroxides, and their properties (1997) (2)
The FIAU Derivative (2′S)-2′-Deoxy-2′-C-Methyl-5-Iodouridine (SMIU) is a Novel, Less Cytotoxic and Potent anti-HSV and anti-VZV Agent (1996) (2)
A NEW APPROACH TO THE SYNTHESIS OF 4′-CARBON-SUBSTITUTED NUCLEOSIDES: DEVELOPMENT OF A HIGHLY ACTIVE ANTI-HIV AGENT 2′, 3′-DIDEHYDRO-3′-DEOXY-4′-ETHYNYLTHYMIDINE (2005) (2)
Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis. (2020) (2)
HTLV-1 Tax peptide-carrying polyion complex nanoparticles induce potent cellular immunity in mice (2014) (2)
Importance of anticomplement immunofluorescence antibody titration for diagnosing varicella-zoster virus infection in Bell's palsy. (1986) (2)
A FACILE SYNTHESIS OF (5-HYDROXY-4-OXO-4H-PYRAN-2-YL)METHYL CARBOXYLATES AND THEIR ANTIVIRAL ACTIVITY AGAINST HEPATITIS C VIRUS (2013) (2)
Synthesis and anti-HIV-1 evaluation of phosphonates which mimic the 5'-monophosphate of 4'-branched 2',3'-didehydro-2',3'-dideoxy nucleosides. (2010) (2)
Development of sugar chain-binding single-chain variable fragment antibody to adult T-cell leukemia cells using glyco-nanotechnology and phage display method (2018) (2)
Induction of E. coli-derived endonuclease MazF suppresses HIV-1 production and causes apoptosis in latently infected cells. (2020) (2)
Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes. (1995) (2)
Synthesis and anti-human immunodeficiency virus activity of the skeleton isomers of 3',4'-Di-(O)-(-)-camphanoyl-(+)-khellactone. (2011) (2)
Synthesis of carbocyclic analogues of 4'-ethynyl- and 4'-cyano-d4T. (2004) (2)
Syntheses of Novel Acyclic Nucleosides, 9-(4'-Hydroxy-2'-methylbut-1'-enyl)-adenine and Related Compounds (1998) (2)
Sulfated polymers as inhibitors of HIV replication (1990) (2)
Non-peptide inhibitors of HIV-1 protease. Synthesis and structural evaluation of symmetric and non-symmetric naphthalenesulfonic acid analogues (1996) (2)
Synthesis of (.+-.)-4′-Ethynyl and 4′-Cyano Carbocyclic Analogues of Stavudine (d4T). (2006) (2)
Orally Active CCR5 Antagonists as anti-HIV-1 Agents. Part 2. Synthesis and Biological Activities of Anilide Derivatives Containing a Pyridine N-Oxide Moiety. (2004) (1)
Synthesis and anti-HIV Activity of 4′-Cyano-2′,3′-didehydro-3′-deoxythymidine. (2004) (1)
Four New Chlorinated Azaphilones, Helicusins A-D, Closely Related to 7- epi-Sclerotiorin, from an Ascomycetous Fungus, Talaromyces helicus. (1996) (1)
Interaction of TIBO and TIBO-like compounds with HIV-1 RT (1991) (1)
In Search of Antiviral Compounds Against the AIDS Virus (1987) (1)
Ribavirin therapy for SSPE virus infection in hamster (1991) (1)
Mechanism of inhibition by piperazinyloxoquinoline derivatives as novel HIV-1 transcription inhibitors (1997) (1)
Nucleosides and Nucleotides. Part 128. (2′S)‐2′‐Deoxy‐2′‐C‐methyl‐5‐ iodouridine (SMIU) as a Novel Potent Anti‐Herpes Virus Agent. (1994) (1)
Antivirał activity of a sulfated polysaccharide extracted from the marine Pseudomonas and marine plant Dinoflagellata against human immunodeficiency viruses and other enveloped viruses (1996) (1)
Polymethylated γ‐Carbolines with Potent anti‐Bovine Viral Diarrhea Virus (BVDV) Activity. (2009) (1)
[Recent progress in anti-HIM-1 research]. (2004) (1)
Long-term culture of HIV-1-infected cells with the transcription inhibitor K-37. (2002) (1)
Potent and selective inhibition of HIV-1 and HIV-2 replication by a novel class of bicyclams targeted at viral uncoating (1992) (1)
First Total Synthesis of Mer‐N5075A and a Diastereomeric Mixture of α‐ and β‐MAPI, New HIV‐1 Protease Inhibitors from a Species of Streptomyces. (2001) (1)
Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1 (2013) (1)
Three-drug combination of MKC-442, 3TC and AZT in vitro: Potential approach towards effective chemotherapy against HIV-1 (1997) (1)
Novel Anti-CD70 Antibody Drug Conjugate for the Treatment of Adult T-Cell Leukemia (ATL) (2020) (1)
Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1: Implication of a new anti-HIV-1 assay in vitro (1995) (1)
Next Generation Anti-HIV Agent 4’-Ethynylstavudine: From the Bench to the Clinic (2015) (1)
Long-term Inhibition of HIV-1 Replication in CD4+ T Cells Transduced with a Retroviral Vector Conditionally Expressing the Escherichia coli Endoribonuclease MazF (2011) (1)
Chemotherapeutic approaches to human immunodeficiency virus infections. (1992) (1)
HEPT Derivatives: 6-Benzyl-1-ethoxymethyl-5-isopropyluracil (MKC-442). (1995) (1)
In vitro drug combination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil with anti-human immunodeficiency virus or anticancer nucleosides (1992) (1)
SJ-3366 Sam Jin Pharmaceutical. (2002) (1)
Establishment of the Haemadsorption-Based Colorimetric Assay for the Screening of Anti-Influenza Compounds (1993) (1)
Synthesis and anti-HBV activity of carbocyclic nucleoside hybrids with salient features of entecavir and aristeromycin. (2020) (1)
γ-Carboline Derivatives as Potent and Selective Inhibitors of Bovine Viral Diarrhea Virus (BVDV) Replication (2010) (1)
Selective Inhibitory Effects of (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine and 2′-Nor-cGMP on the Replication of Adenovirus In Vitro (1987) (1)
Mechanism on antigen delivery under mucosal vaccination using cell-penetrating peptides immobilized at multiple points on polymeric platforms. (2021) (0)
Synthesis and Properties of 1, 3-Divinyltetramethyldisiloxane-Acrylic Acid Co-oligomers (1996) (0)
Anti-Herpes Activities of Isonucleoside Analogues with Variable Bases at the 2′ Position. (1995) (0)
Preparation and Anti‐HIV Activity of O‐Acylated Heparin and Dermatan Sulfate Derivatives with Low Anticoagulant Effect. (2010) (0)
A novel tetramethylnaphthalene derivative selectively inhibits adult T-cell leukemia (ATL) cells in vitro. (2014) (0)
Synthesis of novel 6-substituted acyclouridine derivatives and their anti-HIV-1 activity. (1990) (0)
Synthesis and Anti-human Immunodeficiency Virus Type 1 (HIV-1) Activity of 3-Substituted Derivatives of 3'-Azido-3'-deoxythymidine (AZT), and Inhibition of HIV-1 Reverse Transcriptase by Their 5'-Phosphates. (1993) (0)
Synthesis and structure-activity relationship of thiadiazole derivatives, novel nonnucleoside inhibitors of HIV-1 (1995) (0)
Utilization of Wieland Furoxan Synthesis for Preparation of 4-Aryl-1,2, 5-oxadiazole-3-yl Carbamate Derivatives Having Potent Anti-HIV Activity. (1996) (0)
[Anti-HIV chemotherapy targeted at host-cellular factors]. (1996) (0)
Piperazinyloxoquinoline derivatives, potent and selective inhibitors of HIV-1 transcription (1997) (0)
Study of Attractive Force for Micro Reed Switch (1998) (0)
Synthesis and anti-HIV activity of 4'-C-ethynyl-2'-deoxy-4'-thio-nucleosides. (2009) (0)
Compose tricyclique, procede de production et utilisation dudit compose (2004) (0)
Differential Expression of Host Cellular Factors upon HIV-1 Reactivation (2011) (0)
A novel tetramethylnaphthalene derivative synergistically inhibits HTLV-1-infected cell proliferation in combination with cepharanthine (2011) (0)
Apoptotic Cell Death of Human Monocyte-Driven Activation-Induced (1999) (0)
Inhibition of the Tax-Dependent Human T-Lymphotropic Virus Type 1 (HTLV-1) Replication in Persistently Infected Cells by the Naphthalene Derivative JTK-101 (2007) (0)
In Silico Screening for Anti-HIV-1 Compounds Targeting to Human Cyclin T1 (2009) (0)
Novel RT-PCR Using Sugar Chain-Immobilized Gold-Nanoparticles Correlates Patients’ Symptoms: The Follow-Up Study of COVID-19 Hospitalized Patients (2022) (0)
Naphthalenedisulfonic acid derivatives inhibit HIV-1-induced cytopathogenesis, syncytia formation and virus-cell binding by interaction with the viral envelope glycoprotein (1993) (0)
Leukemia Relapse Mice from Acute Graft-versus-Host Disease TRAIL-Transduced Dendritic Cells Protect (2005) (0)
Synthesis and Antihepatitis C Virus Activity of Morpholino Triazine Derivatives. (2010) (0)
In silico Screening of Compounds Targeting Human Cyclin T1 and In vitro Evaluation of their Anti-HIV-1 Activity (2011) (0)
Synthesis of Hydrophilic Fluorosilane Coupling Oligomers Possessing Anti-Human Immunodeficiency Virus Type-1 Activity (1997) (0)
A Facile Synthesis of (5‐Hydroxy‐4‐oxo‐4H‐pyran‐2‐yl)methyl Carboxylates and Their Antiviral Activity Against Hepatitis C Virus. (2013) (0)
HTLV-1 Tax peptide-carrying polyion complex nanoparticles induce potent cellular immunity in mice (2014) (0)
Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion. (1999) (0)
Bicyclic compound whose production and use (2002) (0)
Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-3 benzyl-3-( 3 , 5-dimethylbenzyl ) uracil derivatives 4 5 Running title : Anti-HIV-1 activity of novel uracil derivatives 6 7 (2012) (0)
Mechanism of inhibitory effect of dextran sulfate (0)
SYNTHESIS OF FLUOROALKYL END-CAPPED OLIGOMERS CONTAINING PENDANT PHOSPHINIC AND PHOSPHONIC ACID SEGMENTS—APPLICATION TO NOVEL FLUORINATED BIOACTIVE POLYMERS POSSESSING ANTIBACTERIAL AND ANTI-HIV-1 ACTIVITIES (2005) (0)
[The history and progress of antiviral research]. (2012) (0)
Polyamino for use as adjuvant (2006) (0)
An antiviral agent for the inhibition of the growth of the AIDS syndrome virus. (1987) (0)
Induction of Innate and Adaptive Immunity with Polyion Complex Nanoparticle Adjuvant Carrying Human Immunodeficiency Virus Type-1 gp120 (2017) (0)
Regioselective Synthesis of Pyrazolo[3,4‐d]pyrimidine Based Carbocyclic Nucleosides as Possible Antiviral Agent. (2016) (0)
Acyclic 6-substituted pyrimidine nucleoside derivatives and antiviral agents containing the same as active agent. (1989) (0)
Migration of dendritic cells and induction of antigen-specific immunity by γ-PGA nanoparticles (2013) (0)
The TIBO-site on HIV-1 reverse transcriptase represents a new target for anti-HIV chemotherapy (1991) (0)
Development of new anti-HIV agents and elucidation of their mechanism of action (1990) (0)
Synthesis of Novel Fluoroalkylated 4‐Vinylpyridinium Chloride Oligomers as Functional Materials Possessing Surfactant and Biological Properties. (1997) (0)
A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev–RRE interaction (2013) (0)
[Antiviral effect of glycyrrhizin on varicella-zoster virus replication in vitro]. (1986) (0)
Médicament anti-virus de l'hépatite b (2016) (0)
Syntheses of Novel Acyclic Nucleosides, 9-(4′-Hydroxy-2′-methylbut-1′-enyl)adenine and Related Compounds. (1998) (0)
in Immunology Uptake of biodegradable poly( γ -glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo (cid:2) (2013) (0)
The anti-HIV activity of 2′, 3′-dideoxyadenosine analogues in vitro (1987) (0)
Marked in vivo antiretrovirus activity of 9-( 2-phosphonylmethoxy-ethyl ) adenine , a selective anti-human immunodeficiency virus agent ( acquired immunodeficiency syndrome / antiviral chemotherapy ) (0)
Stereoselective Synthesis of 4′‐α‐Alkylcarbovir Derivatives Based on an Asymmetric Synthesis or Chemoenzymatic Procedure. (2000) (0)
Clofarabine exhibits multifunctional antiviral activity for hepatoma virus (2016) (0)
Effect of N-acetyl cysteine on cell cycle progression of human cancer cell line (2000) (0)
Broad-spectrum antiviral activity of polyoxometalates against human immunodeficiency virus and other enveloped viruses (1992) (0)
Synthesis and Surfactant Properties of Fluoroalkylated Sulfonic Acid Oligomers as a New Class of Human Immunodeficiency Virus Inhibitors. (1997) (0)
Synthesis and anti‐HIV‐1 Activity of Novel 10‐Thiaisoalloxazines, a Structural Analogue of C‐5 and/or C‐6 Substituted Pyrimidine Acyclonucleoside. (2003) (0)
Intracellular Metabolism and Persistence of the Anti-Human Immunodeﬁciency Virus Activity of 2 (cid:2) ,3 (cid:2) -Didehydro-3 (cid:2) -Deoxy-4 (cid:2) -Ethynylthymidine, a Novel Thymidine Analog (cid:1) (2007) (0)
Impact of Novel Human Immunodeﬁciency Virus Type 1 Reverse Transcriptase Mutations P119S and T165A on 4 (cid:1) -Ethynylthymidine Analog Resistance Proﬁle (cid:1) (2009) (0)
Amphiphilic Poly ( amino acid ) Nanoparticles as Vaccine Carriers and Adjuvants (2013) (0)
Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action (2022) (0)
Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication. (2022) (0)
[Basic approaches to anti-HIV resistance]. (2002) (0)
Anti-Retroviral Vaccine Using Polymeric Nanoparticles (2004) (0)
Anticorps humain capable d'induire une apoptose (2008) (0)
Importance ofanticomplement immunofluorescence antibody titration fordiagnosing varicella-zoster virus infection inBell's palsy (1986) (0)
Antiretroviral effect of nucleoside analogues against in vitro transformation of murine embryo fibroblasts and in vivo tumor induction by moloney murine sarcoma virus. A comparison with their inhibitory effects on human immunodeficiency virus. (1987) (0)
Entry Inhibitors of Human Immunodeficiency Virus (2009) (0)
Polymeres de betaine, leur procede de production et agents antiviraux (1997) (0)
IgG responses to intranasal immunization with cholera-toxin-immobilized polymeric nanospheres in mice (2004) (0)
Development of Vaccine Adjuvants Using Polymeric Nanoparticles and Their Potential Applications for anti‐HIV Vaccine (2007) (0)
Establishment of an in vitro assay system for HIV-1-induced neural cell death and inhibition thereof (2002) (0)
Betain-type fluoroalkylated oligomers are potent inhibitors of human immunodeficiency viruses type 1 (HIV-1) and other enveloped viruses (1997) (0)
Antimyxovirus activities of pyridobenzazole derivatives (1991) (0)
Characterization of seven genotypes (A to E, G and H) of Hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1 (p 24-32) (2005) (0)
9th Walter Brendel Symposiumon Applied Immunology and Microcirculation (1998) (0)
Nanotechnology and antiretroviral therapy (2006) (0)
Synthesis and antiviral evaluation of (+/-)-4'-ethynyl-5'-difluorocarbocyclic-d4T analogue. (2008) (0)
Structural design and anti-HIV-1 evaluation of novel naphthalenedisulfonic acid derivatives (1991) (0)
Sulfonic acid polymers: Highly potent inhibition of HIV-1 and HIV-2 reverse transcriptase and antiviral activity (1993) (0)
Novel 3'-substituted purine 2', 3'-dideoxynucleoside analogs as inhibitors of the human immunodeficiency virus (1988) (0)
Different Properties of Wild Type and Drug‐Resistant Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase In Vitro (1996) (0)
Structure - activity relationship of non-nucleoside RT inhibitor, thiadizaole derivatives (1996) (0)
CRYPTIC DIFFERENTIATION ANTIGENS EXPRESSED ON THE HTLV-I-INFECTED T CELLS. (1999) (0)
Antiviral Activity of Reverse Transcriptase Inhibitors against Porcine Endogenous Retroviruses (PERV) (2007) (0)
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-6123 (2000) (0)
3-dimensional structure studies of thiadiazole-derivatives for anti-HIV-1 RT activity (1995) (0)
A novel tetrahydrotetramethylbenzophenanthridinone derivative inhibits ATL cell proliferation (2014) (0)
Mechanism of Inhibition of Human Immunodeﬁciency Virus Type 1 Reverse Transcriptase by a Stavudine Analogue, 4 (cid:2) -Ethynyl Stavudine Triphosphate (cid:1) (2008) (0)
A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev–RRE interaction (2013) (0)
Bi-cyclic compound, the preparation and use thereof (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Masanori Baba?

Masanori Baba is affiliated with the following schools: